PepGen Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
/ 
Frequently asked questions
To buy PepGen Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for PepGen Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for PepGen Inc. is PEPG:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
PepGen Inc. has its primary listing on NASDAQ. You can trade PepGen Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, PepGen Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include PepGen Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like PepGen Inc..